NCT06502964 - Study of ALTO-101 in Patients With Schizophrenia | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 11, 2024

Primary Completion Date

October 31, 2025

Study Completion Date

November 30, 2025

Conditions

SchizophreniaCognitive Impairment

Interventions

DRUG

ALTO-101

ALTO-101 patches

DEVICE

ALTO-101 Transdermal Delivery System

ALTO-101 transdermal delivery system

DRUG

Placebo

Inactive placebo patches

DEVICE

Placebo Transdermal Delivery System

Placebo transdermal delivery system

Trial Locations (12)

10027

RECRUITING

Site 5108, New York

10032

RECRUITING

Site 5077, New York

10035

RECRUITING

Site 5109, New York

20877

RECRUITING

Site 5062, Gaithersburg

33024

RECRUITING

Site 5060, Hollywood

33629

RECRUITING

Site 5015, Tampa

60640

RECRUITING

Site 5056, Chicago

90015

RECRUITING

Site 5063, Los Angeles

92845

RECRUITING

Site 5038, Garden Grove

92868

RECRUITING

Site 5106, Orange

94596

RECRUITING

Site 5035, Walnut Creek

02478

RECRUITING

Site 5124, Belmont